Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasms × Trastuzumab × Clear all

Phase

Status

Completed 15 Terminated 7 Recruiting 7 Withdrawn 2 Unknown 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 38 Stomach Neoplasms 5 HER2-positive Breast Cancer 4 Neoplasm Metastasis 3 Solid Tumors 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Solid Cancer 1 Patient Compliance 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms, Second Primary 1 Neoplasms 1 Neoplasm, Residual 1 Metastatic Breast Cancer With a Isolated Brain Progression 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Invasive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1 Breast Cancer Invasive 1 Brain Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced HER2+Breast Cancer 1

Interventions

pembrolizumab 26 Cyclophosphamide 17 Nivolumab 16 fludarabine 8 Surveys and Questionnaires 8 Carboplatin 8 atezolizumab 7 Radiotherapy 7 Paclitaxel 7 Exercise 7 Doxorubicin 7 Docetaxel 7 Dexamethasone 7 Bevacizumab 7 venetoclax 6 lenvatinib 6 cabozantinib 6 budigalimab 6 Rituximab 6 Prednisone 6 Fluorouracil 6 Blood Specimen Collection 6 fludarabine phosphate 5 durvalumab 5 avelumab 5 Vincristine 5 Pemetrexed 5 Oxaliplatin 5 Lenalidomide 5 Irinotecan 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04759248 2025-09-09

ATREZZO

SOLTI Breast Cancer Research Group

Phase 2 Active not recruiting

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡